Paracetamol Aurovitas (Paracetamol)

Paracetamol works by inhibiting cyclooxygenase enzymes in the brain and spinal cord, which reduces the production of prostaglandins responsible for pain signaling and temperature regulation. This central action lowers fever and diminishes the perception of pain without significant anti‑inflammatory effects.

The appropriate dose of Paracetamol Aurovitas is determined by the prescribing clinician based on the patient’s age, weight, and clinical condition. Dosage instructions should follow the healthcare provider’s recommendation and the product labeling, and should not exceed the maximum daily limit.

Paracetamol is generally considered compatible with pregnancy and lactation when used at recommended doses, but the decision should be made by a qualified healthcare professional. Pregnant or nursing individuals should discuss any medication use with their doctor to confirm safety for mother and child.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Compared with non‑steroidal anti‑inflammatory drugs (NSAIDs), paracetamol offers effective pain and fever relief with a lower risk of gastrointestinal irritation and platelet inhibition. However, it lacks significant anti‑inflammatory activity, so NSAIDs may be preferred when inflammation control is required.

Paracetamol Aurovitas should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date printed on the label.

The medication is supplied as oral tablets and is taken by mouth with water. It may be taken with or without food, according to the prescribing information. Patients should follow the dosage schedule provided by their healthcare professional.

The most serious risk is hepatotoxicity, which can occur with overdose or when combined with other liver‑affecting substances such as alcohol. Rare but severe reactions include Stevens‑Johnson syndrome, anaphylaxis, and blood disorders. Prompt medical attention is required if any serious symptoms develop.

Individuals with known hypersensitivity to paracetamol or any excipients in the tablet should avoid the product. It is also contraindicated in patients with severe liver disease, chronic alcohol misuse, or those taking multiple hepatotoxic medications without medical supervision.